Shoji Yamanaka

Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism

Kazunori Sango, Shoji Yamanaka, Alexander Hoffmann et al. · Nature Genetics · 1995 · 475 citations

Life Sciences, Neurology, Neuroscience +17

Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial

Takuma Higurashi, Kunihiro Hosono, Hirokazu Takahashi et al. · The Lancet Oncology · 2016 · 340 citations

Medicine, Oncology, Pharmacology +9

Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease.

Shoji Yamanaka, Mark D. Johnson, Alexander Grinberg et al. · Proceedings of the National Academy of Sciences · 1994 · 213 citations

Life Sciences, Genetics, Neuroscience +17

Water‐Tolerant, Highly Active Solid Acid Catalysts Composed of the Keggin‐Type Polyoxometalate H₃PW₁₂O₄₀ Immobilized in Hydrophobic Nanospaces of Organomodified Mesoporous Silica

Kei Inumaru, Tōru Ishihara, Yuichi Κamiya et al. · Angewandte Chemie International Edition · 2007 · 177 citations

Natural Sciences, Chemistry, Materials Science +17

Interstitial pneumonia in Hermansky-Pudlak syndrome: significance of florid foamy swelling/degeneration (giant lamellar body degeneration) of type-2 pneumocytes

Yukio Nakatani, Nobuo Nakamura, Jinyu Sano et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2000 · 146 citations

Medicine, Pathobiology, Pathology +11